BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 7540057)

  • 1. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; PĆ¼rstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trophoblastic diseases].
    ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ; Buck RH; Joubert SM
    S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.